Aegis Sciences Corporation was awarded a firm fixed price definitive contract valued at $17,982,063.34 by the National Institutes of Health's National Heart, Lung and Blood Institute to rapidly develop SARS-CoV-2 test capacity as part of the RADx program. Under the contract, Aegis Sciences, doing business as Aegis Analytical Laboratories in Nashville, Tennessee, will deliver testing services from August 2020 through August 2022 to support the National Institutes of Health's efforts to accelerate COVID-19 diagnostics. The award was made without a set-aside designation to the prime contractor, Aegis Sciences Corporation, to utilize their laboratory facilities and expertise in clinical testing to meet the surge in diagnostic demand resulting from the COVID-19 pandemic.
Generated 12/25/23, 5:23 AM